Angiotensinogen T235 and ACE insertion/deletion polymorphisms associated with albuminuria in Chinese type 2 diabetic patients

Diabetes Care

Volumn 21, Issue 3, 1998, Pages 431-437

  Young, Robert P ^a   Chan, Juliana C N ^a   Critchley, Julian A J H ^a   Poon, Emily ^a   Nicholls, Gary ^a,b   Cockram, Clive S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b University of Christchurch   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHINESE; CLINICAL ARTICLE; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC POLYMORPHISM; HETEROZYGOTE DETECTION; HUMAN; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; RACE DIFFERENCE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADULT; AGE FACTORS; AGED; ALBUMINURIA; ALLELES; AMINO ACID SUBSTITUTION; ANGIOTENSINOGEN; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; CASE-CONTROL STUDIES; CHINA; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DNA TRANSPOSABLE ELEMENTS; FEMALE; GENE FREQUENCY; GENES, RAS; GENOTYPE; HEMOGLOBIN A, GLYCOSYLATED; HONG KONG; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; REGRESSION ANALYSIS; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; SEQUENCE DELETION; SEX FACTORS; TIME FACTORS;

EID: 0031912117     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.3.431     Document Type: Article

References (49)

1. Bader M, Paul M, Fernandez-Alfonso M, Kaling M, Ganten D: Molecular biology and biochemistry of the renin-angiotensin system. In Textbook of Hypertension. Swales JD, Ed. Oxford, U.K., Blackwell Scientific, 1994, p. 214-227
2. Björck S, Aurell M: Diabetes mellitus, the renin-angiotensin system and angiotensin-converting enzyme inhibition. Nephron 55:10-20, 1990
3. Peters J: Molecular basis of human hypertension: the role of angiotensin. Baillieres Clin Endocrinol Metab 9:656-678, 1995
4. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F: Deletion polymorphism in the gene for angiotensin converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644, 1992
5. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F: An insertion deletion polymorphism in angiotensin I convening enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346, 1990
6. Bonnardeaux A, Davies E, Jeunemaitre X, Fery I, Charru A, Clauser E, Tiret L, Cambien F, Corvol P, Sourbrier F: Angiotensin II type 1 receptor gene polymorphism in human essential hypertension. Hypertension 24:63-69, 1994
7. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, Corvol P: Molecular basis of human hypertension: role of angiotensinogen. Cell 71:169-180, 1992
8. Jeunemaitre X, Charru A, Chatellier G, Dumont C, Sassano P, Soubrier F, Menard J, Corvol P: M235T variant of the human angiotensinogen gene in unselected hypertensive patients. J Hypertens 11 (Suppl. 5):S80-S81, 1993
9. Samani NJ, Thompson JR, O'Toole L, Channer K, Woods KL: A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 94:708-712, 1996
10. Tiret L, Bonnardequx A, Poirer O, Ricard S, Marques-Vidai P, Evans A, Arveiler D, Luc G, Kee F, Ducimetiere P, Soubrier F, Cambien F: Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 344:910-913, 1994
11. Katsuya T, Koike G, Yee TW, Sharpe N, Jackson R, Norton R, Horiuchi M, Pratt RE, Dzau VJ, MacMahon S: Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 345:1600-1603, 1995
12. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin converting enzyme inhibition on diabetic nephropathy N Engl J Med 329:1456-1462, 1993
13. Ravid M, Lang R, Bachmani R, Lishner M: Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus: a 7-year follow-up study Arch Intern Med 156:286-289, 1996
14. Parving HH, Tarnow L, Rossing P: Genetics of diabetic nephropathy. J Am Soc Nephrol 7:2509-2517, 1996
15. Marre M, Bernadet P, Gallois Y, Savagner F, Guyene TT, Hallab M, Cambien F, Passa P, Alhenc-Gelas F: Relationships between angiotensin I, converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 43:384-388, 1994
16. Barnas U, Schmidt A, Illievich A, Kiener HP, Rabensteiner D, Kaider A, Prager R, Abrahamian H, Irsigler K, Mayer G: Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control. Diabetologia 40: 327-331, 1997
17. Doria A, Warram JH, Krolewski A: Genetic predisposition to diabetic nephropathy: evidence for a role for the angiotensin-I converting enzyme gene. Diabetes 43:690-695, 1994
18. Schmidt S, Schone N, Ritz E, the Diabetic Nephropathy Study Group: Association of the ACE gene polymorphism and diabetic nephropathy? Kidney Int 47:1176-1181, 1995
19. Tarnow L, Cambien F, Rossing P, Nielsen F, Hansen B, Lecerf L, Poirer O, Danilov S, Parving HH: Lack of relationship between insertion/deletion polymorphism in the angiotensin-I converting enzyme gene and diabetic nephropathy and proliferative retinopathy. Diabetes 44:489-494, 1995
20. Doi Y, Yoshizumi H, Yoshinari M, Iino K, Yamamoto M, Ichikawa K, Iwase M, Fujishima M: Association between a polymorphism in the angiotensin converting enzyme gene and microvascular complications in Japanese patients with NIDDM. Diabetologia 39:97-102, 1996
21. Mizuiri S, Hemmi H, Inoue A, Yoshikawa H, Tanegashima M, Fushimi T, Ishigami M, Amagasaki Y, Ohara T, Shimatake H, Hasegawa A: Angiotensin converting enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus. Nephron 70:455-459, 1995
22. Ohno T, Kawazu S, Tomono S: Association analyses of the polymorphisms of the angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics. Metabolism 45:218-222, 1996
23. Dudley CRK, Keavney B, Stratton IM, Turner RC, Ratcliffe PJ: U.K. Prospective Diabetes Study XV: relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int 48:1907-1911, 1995
24. Fujisawa T, Ikegami K, Shen GQ, Yamato E, Takekawa K, Nakagawa Y, Hamada Y, Ueda H, Gakugi H, Higaki J: Angiotensin I converting enzyme polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy. Diabetes Care 18:983-985, 1995
25. Fogarty DG, Harron JC, Hughes AE, Nevin NC, Doherty CC, Maxwell AP: A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes 45:1204-1208, 1996
26. Doria A, Onuma T, Gearin G, Freire BS, Warram JH, Krolewski AS: Angiotensinogen polymorphisms M235T, hypertension, and nephropathy in insulin-dependent diabetes. Hypertension 27:1134-1139, 1996
27. Chowdhury TA, Dronsfield MJ, Kumar S, Gough SLC, Gibson SP, Khatoon A, MacDonald F, Rowe BR, Dunger DB, Dean JD, Davies SJ, Webber J, Smith PR, Mackin P, Marshall SM, Adu D, Morris PJM, Todd JA, Barnett AH, Boulton AJM, Bain SC: Examination of two genetic polymorphisms within the renin-angiotensin system: no evidence for an association with nephropathy in IDDM. Diobetologia 39:1108-1114, 1996
28. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen B, Ricard S, Poirer O, Parving HH: Angiotensin-II type 1 receptor gene polymorphism and microangiopathy. Nephrol Dial Transplant 11:1019-1023, 1996
29. Marre M, Jeunemaitre X, Gallois Y, Rowdier M, Chatellier G, Set C, Duskier L, Kahn Z, Challis L, Helium S, Mueller A, Sackmann H, Bauduceau B, Bled F, Passa P, Alhenc-Gelas F: Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. J Clin Invest 99:1585-1595, 1997
30. Chan JCN, Cheung CK, Swaminathan R, Nicholls MG, Cockram CS: Obesity, albuminuria and hypertension among Hong Kong Chinese with non-insulin-dependent diabetes mellitus (NIDDM). Postgrad Med J 69:204-210, 1993
31. Chan JCN, Cheung JCK, Lau EMC, Woo J, Swaminathan R, Cockram CS: The metabolic syndrome in Hong Kong Chinese: the interrelationships among its components analyzed by structural equation modeling. Diabetes Care 19:953-959, 1996
32. Nelson RG, Newman JM, Knowler WC, Sievers ML, Kunzelman CL, Pettitt DJ, Moffett CD, Teutsch SM, Bennett PH. Incidence of end-stage renal failure in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia 31:730-736, 1988
33. Allawi J, Rao PV, Gilbert R, Scott G, Jarrett RJ, Keen H, Viberti GC, Mather HM: Microalbuminuria in non-insulin-dependent diabetes: its prevalence in Indian compared with Europoid patients. BMJ 296:462-464, 1988
34. Haffner SM, Mitchell BD, Pugh JA, Stern MP, Kozlowski MK, Hazuda HP, Patterson JK, Klein R: Proteinuria in Mexican Americans and non-Hispanic whites with NIDDM. Diabetes Care 12:530-536, 1989
35. Pettitt DJ, Saad MF, Bennett PH, Nelsen RG, Knowler WC: Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin dependent) diabetes mellitus. Diabetologia 33:438-443, 1990
36. Cowie CC, Port FK, Wolfe RA: Disparities in incidence of diabetes end stage renal disease according to race and type of diabetes. N Engl J Med 321:1074-1079, 1989
37. Johanning GL, Johnston KE, Tamura T, Goldenberg RL: Ethnic differences in angiotensin converting enzyme gene polymorphisms. J Hypertens 13:711-712, 1995
38. Young RP, Sanderson JE, Tomlinson B, Woo KS, Critchley JAJH: Angiotensin converting enzyme deletion-insertion polymorphism in Chinese. J Hypertens 13:1479-1483, 1995
39. Parving H-H, Tarnow L, Rossing P: The angiotensin-converting enzyme gene and its inhibition in diabetic nephropathy. Curr Opin Endocrinol Metab 3:315-321, 1996
40. Mogensen CE, Vestbo E, Poulsen PL, Christiansen C, Damsgaard EM, Eiskjær H, Frøland A, Hansen KW, Nielsen S, Pedersen MM: Microalbuminuria and potential confounders. Diabetes Care 18:572-581, 1995
41. World Health Organization: Arterial Hypertension: Report of a WHO Expert Committee. Geneva, World Health Org., 1978 (Tech. Rep. Ser., no. 628)
42. McGuire GA, Price CP: A continuous monitoring spectrophotometric method for the measurement of ACE in human serum. Ann Clin Biochem 22:204-210, 1985
43. Cheung CK, Swaminathan R: Rapid, economical immunoturbidimetric method for albuminuria. Clin Chem 33:204-205, 1987
44. Tierney MW, McDonald CJ, Luft FC: Renal disease in hypertensive adults: effect of race and type II diabetes mellitus. Am J Kidney Dis 13:485-493, 1989
45. Ravid M, Neumann L, Lishner N: Plasma lipids and the progression of nephropathy in diabetes mellitus type II: effect of ACE inhibitors. Am J Kidney Dis 47:907-910, 1995
46. Parving HH, Anderson AR, Smidt UM, Svendsen PA: Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet i:1175-1178, 1983
47. Moorhead JF, Chan MK, El-Nahas M, Varghese Z: Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet ii:1309-1311, 1982
48. Chan JCN, Cheung CK, Cheung MYF, Swaminathan R, Critchley JAJH, Cockram CS: Abnormal albuminuria as a predictor of mortality and renal impairment in Chinese patients with NIDDM. Diabetes Care 18:1013-1014, 1995
49. Rotimi C, Morrison L, Cooper R, Oyejide C, Effiong E, Ladipo M, Osotemihen B, Ward R: Angiotensinogen gene in human hypertension. Lack of association of the 235 allele among African Americans. Hypertension 24:591-594, 1994